Original articleSpinosad at 0.9% in the treatment of scabies: Efficacy results from 2 multicenter, randomized, double-blind, vehicle-controlled studies
Under a Creative Commons license
open access
Key words
efficacy
Natroba
pediatric
scabies
spinosad
topical
Abbreviation used
AE
adverse event
Cited by (0)
Funding sources: Sponsored and supported by ParaPRO LLC.
IRB approval status: The studies described herein were registered on ClinicalTrials.gov as NCT02485717 and NCT02485704 (both initially posted June 30, 2015). Advarra (formerly known as Schulman IRB), a central institutional review board, reviewed and approved the protocols and associated informed consent/assent forms. Concentrics Research was the contract research organization that planned and conducted the study.
© 2021 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.